MedPath

PHARMORIX OZTIUM FILM COATED TABLET

Registration Number: MAL24016076NC

Approved
Approval ID

8b1e52f4665c4689

Registration Number

MAL24016076NC

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types6 types
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (6)

30 CapsulesAvailable
Package Size: 30 Capsules
Status: NPRA Approved
60 CapsulesAvailable
Package Size: 60 Capsules
Status: NPRA Approved
90 CapsulesAvailable
Package Size: 90 Capsules
Status: NPRA Approved
120 CapsulesAvailable
Package Size: 120 Capsules
Status: NPRA Approved
150 CapsulesAvailable
Package Size: 150 Capsules
Status: NPRA Approved
180 CapsulesAvailable
Package Size: 180 Capsules
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (9)

Cupric Sulfate PentahydrateActive
Monograph: cupric sulfate pentahydrate
VITAMIN K2Active
Monograph: Menaquinone 6
LITHOTHAMNION CALCAREUMActive
Monograph: lithothamnion calcareum
EQUISETUM ARVENSE EXTRACT (HORSETAIL)Active
Monograph: equisetum arvense extract (horsetail)
MAGNESIUM OXIDEActive
Monograph: Magnesium oxide
ZINC OXIDEActive
Monograph: 氧化锌
CALCIUM CARBONATEActive
Monograph: 碳酸钙
Vitamin D3 (Cholecalciferol)Active
Monograph: vitamin d 3 (cholecalciferol)
MANGANESE SULPHATE MONOHYDRATEActive
Monograph: manganese sulphate monohydrate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PHARMORIX OZTIUM FILM COATED TABLET - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform